Researchers discover how hepatitis C virus reprograms human liver cells
This image shows a cultured liver cancer cell infected with hepatitis C. The virus, stained red, surrounds the blue-stained nucleus and is in the process of being reproduced by virus within the cytoplasm. Credit: Photo courtesy of Takahiro Masaki/UNC Lemon Lab
Hepatitis C virus has evolved to invade and hijack the basic machinery of the human liver cell to ensure its survival and spread. Researchers at the University of North have discovered how hepatitis C binds with and repurposes a basic component of cellular metabolism known as a microRNA to help protect and replicate the virus.
In a paper published online in the Proceedings of the National Academy of Sciences Dec. 17, researchers in the laboratory of Stanley M. Lemon, MD, professor of medicine and microbiology and immunology and member of UNC Lineberger Comprehensive Cancer Center, the Center for Translational Immunology, and the UNC Center for Infectious Disease, outline the critical role the microRNA known as miR-122 plays in the life cycle of the hepatitis C virus.
A chronic blood-borne virus that attacks the liver, hepatitis C infects more than four million in the United States and more than 130 million worldwide. Deaths from the infection surpass those due to HIV/AIDS in the U.S. The virus is currently the leading factor in liver transplantation and a major cause of liver cancer, the third most fatal cancer worldwide and the ninth most deadly in the United States. Chronic hepatitis virus infections factor into more than two-thirds of liver cancer deaths.
"There is no cancer in the United States that is increasing in incidence as fast as liver cancer, and that is because of hepatitis C," said Dr. Lemon.
One question has been why hepatitis C virus specifically targets the liver. The research of Dr. Lemon and his colleagues points to the interaction between the hepatitis virus and miR-122 as the explanation.
The human genome contains around 1,000 microRNAs, strands of cellular material that play a diverse role in regulating gene expression and cellular metabolism. In a healthy liver cell, the microRNA miR-122 regulates the activity and decay of numerous cellular RNAs responsible for the production of proteins. It normally functions to block protein expression or to promote degradation of RNAs in the cell. The hepatitis C virus genome is entirely RNA, but miR-122 acts on it in a completely different manner - stabilizing it and enhancing its ability to produce viral proteins. In effect, it promotes and protects the invader.
"MicroRNAs almost always promote the degradation of cellular RNAs. This is actually stabilizing the viral RNA," said Dr. Lemon.
While Dr. Lemon's team has explored the manner in which hepatitis C exploits miR-122 to protect the viral RNA in previous publications, the new research suggests a much deeper bond between the microRNA and virus. Hepatitis C RNA contains a site that binds directly to the microRNA, and the team has shown that the presence of miR122 is actually crucial for functioning of the virus. Dr. Lemon believes the virus has evolved a unique dependency and that it requires the host's microRNA to reproduce.
"It is a relationship that is unique to hepatitis C and not seen, as far as we know, with any other virus," said Dr. Lemon.
Because of the importance of miR-122 to the replication of hepatitis C, the microRNA presents a promising target for new drugs. The pharmaceutical industry has already begun developing therapies that target miR-122. Dr. Lemon said that his research will help explain the underlying biology behind why these drugs work and suggest new possibilities for treatment by targeting other enzymes and proteins that play a role in the interactions between the virus and miR-122.
"If you target miR-122 with a therapeutic that blocks its function or sequesters it so it is no longer accessible to the virus, the replication of the virus is severely impaired," said Dr. Lemon.
Journal reference: Proceedings of the National Academy of Sciences
Provided by University of North Carolina Health Care
- Hepatitis C virus survives by hijacking liver microRNA: study Jan 02, 2012 | not rated yet | 0
- miR-122: Loss of tiny liver molecule might lead to liver cancer Jul 23, 2012 | not rated yet | 0
- Protein found that slows hepatitis C growth in liver cells Apr 27, 2007 | not rated yet | 0
- New data show breakthrough microRNA-targeted therapy holds promise as new treatment for hepatitis C Dec 03, 2009 | not rated yet | 0
- 'Tamed' virus wipes out cancer cells safely May 22, 2009 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011 I'd like to open a discussion thread for version 2 of the draft of my book ''Classical and Quantum Mechanics via Lie algebras'', available online at http://lanl.arxiv.org/abs/0810.1019 , and for the...
- More from Physics Forums - Independent Research
More news stories
(AP)—Federal investigators probing the hantavirus outbreak blamed for three deaths at Yosemite National Park recommend that design changes to tent cabins and other lodging run by private concessionaires first be reviewed ...
Diseases, Conditions, Syndromes 2 hours ago | not rated yet | 0
A new diagnostic test for a worm infection that can lead to severe enlargement and deformities of the legs and genitals is far more sensitive than the currently used test, according to results of a field ...
Diseases, Conditions, Syndromes 3 hours ago | not rated yet | 0 |
A Saudi man who had contracted the coronavirus has died, raising the death toll in the kingdom from the SARS-like virus to 16, the health ministry announced on Monday on its Internet website.
Diseases, Conditions, Syndromes 4 hours ago | not rated yet | 0
A new "telerehabilitation" approach lets physical therapists assess patients with low back pain (LBP) over the Internet, with good accuracy compared with face-to-face examinations, reports a study in the May 15 issue of Sp ...
Diseases, Conditions, Syndromes 5 hours ago | not rated yet | 0
A study of older patients with chronic obstructive pulmonary disease (COPD) suggests that new use of the long-acting bronchodilators β-agonists and anticholinergics was associated with similar increased risks of cardiovascular ...
Diseases, Conditions, Syndromes 5 hours ago | not rated yet | 0
New research suggests that a compound abundant in the Mediterranean diet takes away cancer cells' "superpower" to escape death. By altering a very specific step in gene regulation, this compound essentially re-educates cancer ...
5 hours ago | 4.7 / 5 (7) | 1 |
Researchers have pinpointed a catalytic trigger for the onset of Alzheimer's disease – when the fundamental structure of a protein molecule changes to cause a chain reaction that leads to the death of neurons ...
6 hours ago | 5 / 5 (2) | 0 |
Salamanders' immune systems are key to their remarkable ability to regrow limbs, and could also underpin their ability to regenerate spinal cords, brain tissue and even parts of their hearts, scientists have ...
6 hours ago | 5 / 5 (1) | 0 |
Turns out, that old "practice makes perfect" adage may be overblown. New research led by Michigan State University's Zach Hambrick finds that a copious amount of practice is not enough to explain why people ...
3 hours ago | 3.6 / 5 (5) | 0 |
(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.
2 hours ago | 4.3 / 5 (6) | 1 |
Older prostate cancer patients with other underlying health conditions should think twice before committing to surgery or radiation therapy for their cancer, according to a multicenter study led by researchers in the UCLA ...
3 hours ago | not rated yet | 0 |